RF vs RYTM
RF (RF) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
RF (RF) common stock.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
RF does not have a complete income-statement cache yet.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
RF currently screens at market cap $0. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the RF and RYTM stock pages for the full models.
Not investment advice.